[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB201610628D0 - New compositions - Google Patents

New compositions

Info

Publication number
GB201610628D0
GB201610628D0 GBGB1610628.8A GB201610628A GB201610628D0 GB 201610628 D0 GB201610628 D0 GB 201610628D0 GB 201610628 A GB201610628 A GB 201610628A GB 201610628 D0 GB201610628 D0 GB 201610628D0
Authority
GB
United Kingdom
Prior art keywords
new compositions
compositions
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1610628.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GBGB1610628.8A priority Critical patent/GB201610628D0/en
Publication of GB201610628D0 publication Critical patent/GB201610628D0/en
Priority to PCT/GB2017/051782 priority patent/WO2017216584A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1610628.8A 2016-06-17 2016-06-17 New compositions Ceased GB201610628D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1610628.8A GB201610628D0 (en) 2016-06-17 2016-06-17 New compositions
PCT/GB2017/051782 WO2017216584A1 (en) 2016-06-17 2017-06-19 New compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1610628.8A GB201610628D0 (en) 2016-06-17 2016-06-17 New compositions

Publications (1)

Publication Number Publication Date
GB201610628D0 true GB201610628D0 (en) 2016-08-03

Family

ID=56895328

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1610628.8A Ceased GB201610628D0 (en) 2016-06-17 2016-06-17 New compositions

Country Status (2)

Country Link
GB (1) GB201610628D0 (en)
WO (1) WO2017216584A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11040027B2 (en) 2017-01-17 2021-06-22 Heparegenix Gmbh Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
CN108938584B (en) * 2018-08-17 2021-01-26 湖北欣瑞康医药科技有限公司 Tablet containing VEGF receptor inhibitor Tivozanib salt and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2859919B2 (en) * 1990-03-15 1999-02-24 旭化成工業株式会社 Method for improving dissolution of poorly soluble drugs
EP1712583B1 (en) * 2004-01-30 2020-09-16 Asahi Kasei Kabushiki Kaisha Porous cellulose aggregate and formed product composition comprising the same
JP5240822B2 (en) * 2005-04-22 2013-07-17 旭化成ケミカルズ株式会社 Porous cellulose aggregate and molded body composition thereof
US9687536B2 (en) * 2010-04-15 2017-06-27 Shin Nippon Biomedical Laboratories, Ltd. Methods and compositions for intranasal delivery

Also Published As

Publication number Publication date
WO2017216584A1 (en) 2017-12-21

Similar Documents

Publication Publication Date Title
IL261792B (en) Compositions
IL260933A (en) Plinabulin compositions
SG11201705415YA (en) Multi-supplement compositions
GB201610156D0 (en) Cliptac compositions
IL257131A (en) Compositions
HK1251559A1 (en) Plinabulin compositions
GB201501598D0 (en) Compositions
GB201515387D0 (en) Compositions
GB201515391D0 (en) Compositions
GB201600075D0 (en) Immunogenci composition
SI3349766T1 (en) Anti-hemorrhaging compositions
GB201614799D0 (en) Compositions
EP3443034C0 (en) Composition
GB201622161D0 (en) Compositions
GB201902573D0 (en) Composition
EP3413873C0 (en) New compositions
GB201610628D0 (en) New compositions
GB2538335B (en) Compositions
HUE050837T2 (en) Compositions
GB201602658D0 (en) Compositions
GB201607924D0 (en) Composition
GB201614230D0 (en) Compositions
GB201611960D0 (en) Compositions
GB201611851D0 (en) Compositions
GB201602656D0 (en) Compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)